Navigation Links
SCOLR Pharma, Inc. First Quarter 2011 Financial Results
Date:5/9/2011

60;31, 20104949Additional paid-in capital77,11577,041Accumulated deficit(75,271)(74,049)Total stockholders' equity1,8933,041$

2,589$

3,858SCOLR Pharma, Inc.CONDENSED UNAUDITED STATEMENTS OF OPERATIONS(In thousands, except per share amounts and number of shares)Three months endedMarch 31, 20112010(Restated) RevenuesLicensing fees$

—$

25Royalty income66141Research and development 118—Total revenues184166Operating expensesMarketing and selling12559Research and development647340General and administrative740601Total operating expenses1,5121,000Loss from operations(1,328)(834)Other income (expense)Interest income11Unrealized gain (loss) on fair value of warrant105(218)Total other income (expense)106(217)Net loss$

(1,222)$

(1,051)Net loss per share, basic and diluted$

(0.02)$

(0.02)Shares used in computing basic and diluted net loss per share49,816,07343,140,968Contacts:
Investor Relations:
SCOLR Pharma, Inc.
425.368.1050


'/>"/>
SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
4. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
5. SCOLR Pharma, Inc. Licenses Dietary Supplements
6. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
7. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
8. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
9. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
10. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
11. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... CARLSBAD, Calif. , June 19, 2013 /PRNewswire/ ... ) today announces a licensing agreement granting Suzhou ... develop and manufacture siRNA therapeutics in ... technology.  Ribo will formulate proprietary siRNA molecules in ... platform designed to address human diseases with high ...
(Date:6/19/2013)... may seem like an odd pairing: an oral growth hormone-boosting ... two of the most talked about topics at ENDO 2013, ... that just convened in San Francisco . ... the top internal medicine experts in the world is very ... not only save lives, but help people feel and ...
(Date:6/18/2013)... MT. PROSPECT, Ill. , June 18, 2013 ... availability of its new X3130 Appliance Inlet Module. ... thermal circuit breaker , combines a C14 appliance ... in one compact package.  This three-in-one device allows ... in their designs - cutting installation time by ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Three-in-One X3130 Appliance Inlet Module 2
... PINE BROOK, N.J. and BASEL, Switzerland , ... an agreement for the scale-up and commercial production of Anthim, ... of inhaled anthrax. Under the new contract, Lonza will provide ... of its facilities in the USA . The manufacturing ...
... , July 15 The ... Dermatology (JDD ), a full-color, peer-reviewed publication serving the dermatology ... and tolerability of the active ingredient in PyratineXR™.  The results ... the flagship product in the new advanced skincare line that ...
Cached Medicine Technology:Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development 2Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development 3Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development 4Study of Long-Term Efficacy and Safety of New PyratineXR™ Moisturizing Lotion Featured in Journal of Drugs in Dermatology 2Study of Long-Term Efficacy and Safety of New PyratineXR™ Moisturizing Lotion Featured in Journal of Drugs in Dermatology 3Study of Long-Term Efficacy and Safety of New PyratineXR™ Moisturizing Lotion Featured in Journal of Drugs in Dermatology 4Study of Long-Term Efficacy and Safety of New PyratineXR™ Moisturizing Lotion Featured in Journal of Drugs in Dermatology 5
(Date:6/19/2013)... 19, 2013 Amerinet, Inc, a ... Healthcare Technologies to help Pacific Medical Centers implement ... of more than 17 percent over the organization’s ... , “Driving economies of scale and process standardization ... challenges facing multi-site providers,” said Shawn Padilla, director ...
(Date:6/19/2013)... Elsevier, a world-leading provider of scientific, technical ... the publication of the National Osteoporosis Guideline Group ... osteoporosis in postmenopausal women and older men in ... 2009 in Maturitas , the original guidelines ... timely with an additional focus on the management ...
(Date:6/19/2013)... June 19, 2013 Imprivata ®, ... today announced that Imprivata OneSign ® leads the ... Mid-Term Performance Review: Software & Services report . CIOs ... Imprivata on the superior performance of its products and ... they indicate that Imprivata is integral to their long-term ...
(Date:6/19/2013)... 2013 According to Transparency Market Research ... Trends, Analysis and Forecast, 2011 – 2017,” the global ... the year 2011 and is expected to reach USD ... 9.7% from 2011 to 2017. Flexible endoscopes formed the ... USD 2,201 million for the year 2011. , Related ...
(Date:6/19/2013)... Despite the fact that the incidence of cancer is ... age, we still have an inadequate understanding on how ... though elderly patients are occasionally included in clinical trials, ... ,healthy, (fit) elderly patients. Thus, the broader elderly patient ... EORTC Cancer in the Elderly Task Force is now ...
Breaking Medicine News(10 mins):Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2
... of humour or great look is whats really needed to make ... poll by online dating agency Match.com reveals that one in three ... ,Eight out of the ten people who answered the ... was likely to mean the end of a relationship. ...
... Nations World Food Programme (WFP) has warned that continuing security ... especially in the west of the country where food stocks ... may soon see critical food supplies curtailed or interrupted. ... western region of Afghanistan for four weeks due to insecurity. ...
... shown that bone marrow stem cells injected into a ... hearing loss. ,Hearing loss has many ... complete or partial. Such loss may involve damage to ... to inner ear function. ,Some natural regeneration ...
... of 2,785 college students indicates that more than half of ... not seek help and studies show that the incidence of ... is despite the fact that resources are available at no ... University of Michigan School of Public Health. Eisenberg and doctoral ...
... Regulation Ministerial Council (ANZFRMC) has responded to calls from the ... folate fortification of flour for bread making. ,ANZFRMC now ... bread making to be implemented by 2009. ,Chair ... Thomas, said today that the AMA has been calling for ...
... to finding a cure and developing new, effective drugs to ... in New South Wales each year. ,The new research ... undertake crucial research in cancer. It is the largest ... for Australia. ,The centre, an Australian first to establish ...
Cached Medicine News:Health News:Insecurity Jepardising WFP Initiatives in Western Afghanistan 2Health News:Stem Cells Aid in Hearing Recovery 2Health News:A New Survey -Anxiety Students Dont Seek Help 2Health News:New Research Centre at Sydney to Lead Cancer Fight 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: